Literature DB >> 16847335

CXCR3 requires tyrosine sulfation for ligand binding and a second extracellular loop arginine residue for ligand-induced chemotaxis.

Richard A Colvin1, Gabriele S V Campanella, Lindsay A Manice, Andrew D Luster.   

Abstract

CXCR3 is a G-protein-coupled seven-transmembrane domain chemokine receptor that plays an important role in effector T-cell and NK cell trafficking. Three gamma interferon-inducible chemokines activate CXCR3: CXCL9 (Mig), CXCL10 (IP-10), and CXCL11 (I-TAC). Here, we identify extracellular domains of CXCR3 that are required for ligand binding and activation. We found that CXCR3 is sulfated on its N terminus and that sulfation is required for binding and activation by all three ligands. We also found that the proximal 16 amino acid residues of the N terminus are required for CXCL10 and CXCL11 binding and activation but not CXCL9 activation. In addition, we found that residue R216 in the second extracellular loop is required for CXCR3-mediated chemotaxis and calcium mobilization but is not required for ligand binding or ligand-induced CXCR3 internalization. Finally, charged residues in the extracellular loops contribute to the receptor-ligand interaction. These findings demonstrate that chemokine activation of CXCR3 involves both high-affinity ligand-binding interactions with negatively charged residues in the extracellular domains of CXCR3 and a lower-affinity receptor-activating interaction in the second extracellular loop. This lower-affinity interaction is necessary to induce chemotaxis but not ligand-induced CXCR3 internalization, further suggesting that different domains of CXCR3 mediate distinct functions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16847335      PMCID: PMC1592751          DOI: 10.1128/MCB.00556-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  50 in total

1.  IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection.

Authors:  I A Khan; J A MacLean; F S Lee; L Casciotti; E DeHaan; J D Schwartzman; A D Luster
Journal:  Immunity       Date:  2000-05       Impact factor: 31.745

2.  Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis.

Authors:  Simona Frigerio; Tobias Junt; Bao Lu; Craig Gerard; Urs Zumsteg; Georg A Holländer; Luca Piali
Journal:  Nat Med       Date:  2002-11-04       Impact factor: 53.440

3.  The Sulfinator: predicting tyrosine sulfation sites in protein sequences.

Authors:  Flavio Monigatti; Elisabeth Gasteiger; Amos Bairoch; Eva Jung
Journal:  Bioinformatics       Date:  2002-05       Impact factor: 6.937

4.  Sulphated tyrosines mediate association of chemokines and Plasmodium vivax Duffy binding protein with the Duffy antigen/receptor for chemokines (DARC).

Authors:  Hyeryun Choe; Michael J Moore; Christopher M Owens; Paulette L Wright; Natalya Vasilieva; Wenhui Li; Agam P Singh; Rushdi Shakri; Chetan E Chitnis; Michael Farzan
Journal:  Mol Microbiol       Date:  2005-03       Impact factor: 3.501

5.  The role of post-translational modifications of the CXCR4 amino terminus in stromal-derived factor 1 alpha association and HIV-1 entry.

Authors:  Michael Farzan; Gregory J Babcock; Natalya Vasilieva; Paulette L Wright; Enko Kiprilov; Tajib Mirzabekov; Hyeryun Choe
Journal:  J Biol Chem       Date:  2002-05-28       Impact factor: 5.157

6.  Structure and function of the murine chemokine receptor CXCR3.

Authors:  B Lu; A Humbles; D Bota; C Gerard; B Moser; D Soler; A D Luster; N P Gerard
Journal:  Eur J Immunol       Date:  1999-11       Impact factor: 5.532

7.  Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells.

Authors:  F Mach; A Sauty; A S Iarossi; G K Sukhova; K Neote; P Libby; A D Luster
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

8.  Tyrosine sulfation of CCR5 N-terminal peptide by tyrosylprotein sulfotransferases 1 and 2 follows a discrete pattern and temporal sequence.

Authors:  Christoph Seibert; Martine Cadene; Anthony Sanfiz; Brian T Chait; Thomas P Sakmar
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-08       Impact factor: 11.205

9.  The CXCR3 binding chemokine IP-10/CXCL10: structure and receptor interactions.

Authors:  Valerie Booth; David W Keizer; Monique B Kamphuis; Ian Clark-Lewis; Brian D Sykes
Journal:  Biochemistry       Date:  2002-08-20       Impact factor: 3.162

10.  Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection.

Authors:  David Xiao-Ming Zhao; Yenya Hu; Geraldine G Miller; Andrew D Luster; Richard N Mitchell; Peter Libby
Journal:  J Immunol       Date:  2002-08-01       Impact factor: 5.422

View more
  59 in total

1.  Sulfopeptide probes of the CXCR4/CXCL12 interface reveal oligomer-specific contacts and chemokine allostery.

Authors:  Joshua J Ziarek; Anthony E Getschman; Stephen J Butler; Deni Taleski; Bryan Stephens; Irina Kufareva; Tracy M Handel; Richard J Payne; Brian F Volkman
Journal:  ACS Chem Biol       Date:  2013-06-26       Impact factor: 5.100

Review 2.  CXCR3 in carcinoma progression.

Authors:  Bo Ma; Ahmad Khazali; Alan Wells
Journal:  Histol Histopathol       Date:  2015-02-09       Impact factor: 2.303

3.  Identification of a novel immunomodulatory gliadin peptide that causes interleukin-8 release in a chemokine receptor CXCR3-dependent manner only in patients with coeliac disease.

Authors:  Karen M Lammers; Sunaina Khandelwal; Fatima Chaudhry; Debby Kryszak; Elaine L Puppa; Vincenzo Casolaro; Alessio Fasano
Journal:  Immunology       Date:  2010-11-23       Impact factor: 7.397

4.  Biased agonists of the chemokine receptor CXCR3 differentially control chemotaxis and inflammation.

Authors:  Jeffrey S Smith; Lowell T Nicholson; Jutamas Suwanpradid; Rachel A Glenn; Nicole M Knape; Priya Alagesan; Jaimee N Gundry; Thomas S Wehrman; Amber Reck Atwater; Michael D Gunn; Amanda S MacLeod; Sudarshan Rajagopal
Journal:  Sci Signal       Date:  2018-11-06       Impact factor: 8.192

5.  Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3.

Authors:  Karen M Lammers; Ruliang Lu; Julie Brownley; Bao Lu; Craig Gerard; Karen Thomas; Prasad Rallabhandi; Terez Shea-Donohue; Amir Tamiz; Sefik Alkan; Sarah Netzel-Arnett; Toni Antalis; Stefanie N Vogel; Alessio Fasano
Journal:  Gastroenterology       Date:  2008-03-21       Impact factor: 22.682

6.  Tyrosine sulfation of leukocyte adhesion molecules and chemokine receptors promotes atherosclerosis.

Authors:  Ekaterina Koltsova; Klaus Ley
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-11       Impact factor: 8.311

Review 7.  CXCR3 ligands: redundant, collaborative and antagonistic functions.

Authors:  Joanna R Groom; Andrew D Luster
Journal:  Immunol Cell Biol       Date:  2011-01-11       Impact factor: 5.126

Review 8.  Opportunities for therapeutic antibodies directed at G-protein-coupled receptors.

Authors:  Catherine J Hutchings; Markus Koglin; William C Olson; Fiona H Marshall
Journal:  Nat Rev Drug Discov       Date:  2017-07-14       Impact factor: 84.694

Review 9.  Role of tyrosine-sulfated proteins in retinal structure and function.

Authors:  Y Kanan; M R Al-Ubaidi
Journal:  Exp Eye Res       Date:  2015-04       Impact factor: 3.467

10.  Mass spectrometric kinetic analysis of human tyrosylprotein sulfotransferase-1 and -2.

Authors:  Lieza M Danan; Zhihao Yu; Adam J Hoffhines; Kevin L Moore; Julie A Leary
Journal:  J Am Soc Mass Spectrom       Date:  2008-07-01       Impact factor: 3.109

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.